Home - Products - Others - Other Targets - CFTR (108-117), Pseudomonas aeruginosa Inhibitor

CFTR (108-117), Pseudomonas aeruginosa Inhibitor

CAS No. ———

CFTR (108-117), Pseudomonas aeruginosa Inhibitor( ——— )

Catalog No. M41328 CAS No. ———

CFTR (108-117), Pseudomonas aeruginosa Inhibitor

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CFTR (108-117), Pseudomonas aeruginosa Inhibitor
  • Note
    Research use only, not for human use.
  • Brief Description
    CFTR (108-117), Pseudomonas aeruginosa Inhibitor
  • Description
    CFTR (108-117), Pseudomonas aeruginosa Inhibitor
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    1252.27
  • Molecular Formula
    C51H77N15O22
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 3-Hydroxymollugin

    3-Hydroxymollugin are cytotoxic compounds isolated from Pentas longiflora and Rubia cordifolia.

  • E-3030

    E-3030 free acid is a potent dual activator of peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma, exhibiting significant antidiabetic and lipid-modulating effects. E-3030 decreases blood glucose, triglyceride, non-esterified fatty acids, and insulin levels, while increasing blood adiponectin levels. E-3030 improves glucose tolerance and shows remarkable triglyceride- and non-high-density lipoprotein cholesterol-lowering effects in animal models.

  • Omalizumab

    Omalizumab is a recombinant humanized monoclonal antibody against human immunoglobulin E IgE).